<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Therapeutic Challenges** * **cGAS-STING Pathway:** Makalenin ana konusu bu sinyal yoludur. * **Cancer Immunotherapy:** cGAS-STING&#8217;in modülasyonu &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/therapeutic-challenges-cgas-sting-pathway-makalenin-ana-konusu-bu-sinyal-yoludur-cancer-immunotherapy-cgas-stingin-modulasyonu/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 04:57:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Therapeutic Challenges** * **cGAS-STING Pathway:** Makalenin ana konusu bu sinyal yoludur. * **Cancer Immunotherapy:** cGAS-STING&#8217;in modülasyonu &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Targeting cGAS–STING in Cancer: Opportunities and Challenges</title>
		<link>https://bioengineer.org/targeting-cgas-sting-in-cancer-opportunities-and-challenges/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 04:56:42 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[cGAS-STING Yolu]]></category>
		<category><![CDATA[cGAS-STING'in kanser tedavisindeki rolü bu ba]]></category>
		<category><![CDATA[combination therapy]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Kanser İmmünoterapisi]]></category>
		<category><![CDATA[kanser immünoterapisinde bir strateji olarak ele alınıyor. * **]]></category>
		<category><![CDATA[Kişiselleştirilmiş Tedavi** * **Kanser İmmünoterapisi:** Makalenin temel konusu]]></category>
		<category><![CDATA[Kombinasyon Terapisi]]></category>
		<category><![CDATA[Makale içeriğine uygun 5 etiket: **cGAS-STING Pathway]]></category>
		<category><![CDATA[Therapeutic Challenges** * **cGAS-STING Pathway:** Makalenin ana konusu bu sinyal yoludur. * **Cancer Immunotherapy:** cGAS-STING'in modülasyonu]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<category><![CDATA[Tümör mikroçevresi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/targeting-cgas-sting-in-cancer-opportunities-and-challenges/</guid>

					<description><![CDATA[The cGAS–STING pathway has emerged as a pivotal mechanism in the landscape of immuno-oncology, particularly in its role in detecting tumor-derived DNA. This pathway initiates a cascade of immune responses that can either promote or suppress tumor growth, reflecting the dual nature of inflammatory signals within the tumor microenvironment. At its core, cyclic guanosine monophosphate [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318133</post-id>	</item>
	</channel>
</rss>
